These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15699764)

  • 1. Maintenance immunosuppression use and the associated risk of avascular necrosis after kidney transplantation in the United States.
    Abbott KC; Koff J; Bohen EM; Oglesby RJ; Agodoa LY; Lentine KL; Schnitzler MA
    Transplantation; 2005 Feb; 79(3):330-6. PubMed ID: 15699764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential risks for adverse outcomes 3 years after kidney transplantation based on initial immunosuppression regimen: a national study.
    Dharnidharka VR; Schnitzler MA; Chen J; Brennan DC; Axelrod D; Segev DL; Schechtman KB; Zheng J; Lentine KL
    Transpl Int; 2016 Nov; 29(11):1226-1236. PubMed ID: 27564782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
    Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Better actual 10-year renal transplant outcomes of 80% reduced cyclosporine exposure with sirolimus base therapy compared with full cyclosporine exposure without or with concomittant sirolimus treatment.
    Pliszczynski J; Kahan BD
    Transplant Proc; 2011 Dec; 43(10):3657-68. PubMed ID: 22172822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo immunosuppression with sirolimus and tacrolimus in heart transplant recipients compared with cyclosporine and mycophenolate mofetil: a one-year follow-up analysis.
    Zucker MJ; Baran DA; Arroyo LH; Goldstein DJ; Neacy C; Mele L; Weinberg AD; Prendergast TW; Ribner HS
    Transplant Proc; 2005 Jun; 37(5):2231-9. PubMed ID: 15964386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospitalized avascular necrosis after renal transplantation in the United States.
    Abbott KC; Oglesby RJ; Agodoa LY
    Kidney Int; 2002 Dec; 62(6):2250-6. PubMed ID: 12427153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.
    Jaber JJ; Feustel PJ; Elbahloul O; Conti AD; Gallichio MH; Conti DJ
    Clin Transplant; 2007; 21(1):101-9. PubMed ID: 17302598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of USRDS: incidence and risk factors for Pneumocystis jiroveci pneumonia.
    Neff RT; Jindal RM; Yoo DY; Hurst FP; Agodoa LY; Abbott KC
    Transplantation; 2009 Jul; 88(1):135-41. PubMed ID: 19584693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination.
    Gonwa TA; Hricik DE; Brinker K; Grinyo JM; Schena FP;
    Transplantation; 2002 Dec; 74(11):1560-7. PubMed ID: 12490789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirolimus-based immunosuppression with reduce dose cyclosporine or tacrolimus after renal transplantation.
    Formica RN; Lorber KM; Friedman AL; Bia MJ; Lakkis F; Smith JD; Lorber MI
    Transplant Proc; 2003 May; 35(3 Suppl):95S-98S. PubMed ID: 12742475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectiveness and safety of conversion therapy with the combination of sirolimus with low dose cyclosporine in renal transplantation recipients: a five-year clinical observation].
    Zhu L; Ding T; Wang XX; Lin ZB; Chen G
    Zhonghua Yi Xue Za Zhi; 2016 May; 96(20):1556-61. PubMed ID: 27266681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine use and male gender are independent determinants of avascular necrosis after kidney transplantation: a cohort study.
    Schachtner T; Otto NM; Reinke P
    Nephrol Dial Transplant; 2018 Nov; 33(11):2060-2066. PubMed ID: 29868874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Switching immunosuppression medications after renal transplantation--a common practice.
    Meier-Kriesche HU; Chu AH; David KM; Chi-Burris K; Steffen BJ
    Nephrol Dial Transplant; 2006 Aug; 21(8):2256-62. PubMed ID: 16574677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.
    Sundberg AK; Rohr MS; Hartmann EL; Adams PL; Stratta RJ
    Clin Transplant; 2004; 18 Suppl 12():61-6. PubMed ID: 15217410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation.
    Opelz G; Döhler B;
    Transplantation; 2009 Mar; 87(6):795-802. PubMed ID: 19300179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid withdrawal in renal transplant recipients.
    Oppenheimer F
    Transplant Proc; 2000 Feb; 32(1A Suppl):14S-15S. PubMed ID: 10686314
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.
    Gallon LG; Winoto J; Chhabra D; Parker MA; Leventhal JR; Kaufman DB
    Transplantation; 2007 May; 83(10):1324-9. PubMed ID: 17519781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
    Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J
    Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.